BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1283273)

  • 1. [Clinical and prognosis relevance of the Kiel classification of non-Hodgkin lymphomas].
    Brittinger G; Engelhard M
    Verh Dtsch Ges Pathol; 1992; 76():37-46. PubMed ID: 1283273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy].
    Hiddemann W
    Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
    Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
    Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
    Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
    Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.
    Diaz JI; Edinger MG; Stoler MH; Tubbs RR
    Am J Pathol; 1991 Sep; 139(3):503-9. PubMed ID: 1887860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.
    Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA
    Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
    Pituch-Noworolska A; Miezyński W
    Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-Hodgkin's lymphomas: principles and application of the Kiel classification].
    Lennert K
    Verh Dtsch Ges Pathol; 1992; 76():1-13. PubMed ID: 1283238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.
    Stauder R; Greil R; Schulz TF; Thaler J; Gattringer C; Radaskiewicz T; Dierich MP; Huber H
    Clin Exp Immunol; 1989 Aug; 77(2):234-8. PubMed ID: 2673591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
    Teske E; Wisman P; Moore PF; van Heerde P
    Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
    Glińska H; Papla B; Siuda M; Zulichowska J
    Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pulmonary lymphoma: relationship between clinical features and pathologic findings in 24 cases. The Japan National Chest Hospital Study Group for Lung Cancer.
    Tamura A; Komatsu H; Yanai N; Homma J; Nagase A; Nemoto E; Hirai T; Hashizume T; Kawata K; Ishikawa S
    Jpn J Clin Oncol; 1995 Aug; 25(4):140-52. PubMed ID: 7666590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of low-grade non-Hodgkin's lymphoma].
    Heinz R; Hopfinger-Limberger G
    Wien Klin Wochenschr; 1994; 106(10):321-6. PubMed ID: 8053200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between clinical parameters and histologic findings in patients with non-Hodgkin's lymphoma].
    Planinc-Peraica A; Jaksić B; Pisl Z; Dominis M
    Acta Med Iugosl; 1991; 45(3):231-44. PubMed ID: 1950642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transformation of malignant non-Hodgkin's lymphomas from low- to high-grade malignancy].
    Herait P; Audouin J; Rio B; Zylberait D; Marie JP; Diebold J; Zittoun R
    Ann Med Interne (Paris); 1986; 137(4):342-5. PubMed ID: 3777743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
    Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
    Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.